Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group. - Sehouli,J.; Stengel,D.; Oskay-Oezcelik,G. (J Clin Oncol, 2008)